Estrogen and heart disease
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
The government funding prospective study of the safety and efficacy of hormone replacement therapy in the menopause practically stopped the routine prescription of estrogen overnight. Why? Our guest today is Dr. Richard Karas, Professor of Medicine, at the Tufts University School of Medicine in Boston. He has several titles including: Co-Director, Molecular Cardiology Research Center, Director, Preventive Cardiology and Director, Women’s Heart Center at the New England Medical Center. He received his MD from Tufts and his Ph.D in Physiology from Harvard.
Overview
The government funding prospective study of the safety and efficacy of hormone replacement therapy in the menopause practically stopped the routine prescription of estrogen overnight. Why? Our guest today is Dr. Richard Karas, Professor of Medicine, at the Tufts University School of Medicine in Boston. He has several titles including: Co-Director, Molecular Cardiology Research Center, Director, Preventive Cardiology and Director, Women’s Heart Center at the New England Medical Center. He received his MD from Tufts and his Ph.D in Physiology from Harvard.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Bridging Distances in PAH: Bringing Best Practices to the People Through Telementoring
Partnering with Patients: Building Effective Communication and Support in HF Care
Clinical Conundrums in ARIA: Differential Diagnoses and Potential Pitfalls in ARIA Evaluation
Clinical Conundrums in ARIA: How to Manage Asymptomatic ARIA
Pulmonary Hypertension Management: Practice Trends and Updates
Distinguishing Between Anti-PD-1 Agents in ESCC Combination Therapies
Evaluating Sleep Deprivation as a Risk Factor for Postpartum Depression
Bladders, Breakthroughs, and Bold New Therapies: Key Updates at AUA 2025
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?